Catalent creates commercial excellence role

Appoints Jeremie Trochu to the position

Catalent Pharma Solutions has appointed Jeremie Trochu to the newly created position of vice president, commercial excellence.

Trochu joins Catalent from General Electric, where he was most recently general manager of sales resource optimisation within the firm’s healthcare division. Prior to that, he was commercial transformation leader for GE Healthcare.

‘As Catalent continues to grow with investments in acquisitions, drug delivery technologies, new capabilities and site expansions, I am excited to have Jeremie join the Catalent team to help enhance our sales capabilities across all offerings. He brings significant commercial experience to Catalent,’ said Will Downie, senior vice president of global sales and marketing at Catalent.

You may also like

Manufacturing

Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation

Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its large-scale spray drying unit (GEA PSD-4) at its Boston (MA, US) facility
Manufacturing

Catalent expands integrated development, manufacturing and supply for modalities

Originally launched in 2019 for early-phase protein therapy development, OneBio Suite offers customers an integrated service
Manufacturing

Catalent adds cryogenic capabilities to support gene development

The facility in Shiga will include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials
Manufacturing

Catalent begins $20 million construction project

The project creates space in the original building to accommodate the installation of a new, fully automatic bottle filling line
Manufacturing

Catalent and Bhami announce licensing agreement

Catalent will be authorised to collaborate with its customers to evaluate BRL’s formulation technology
Manufacturing

Catalent expands platform process for viral vectors

Processes can now benefit through increased consistency and efficiency, potentially reducing the time
Manufacturing

Catalent completes $2.2 million expansion to clinical supply facility

The site in Singapore serves the Asia-Pacific region with a wide range of clinical supply services
Subscribe now